Sachin Chandran,Rajesh Babulal Gandhi,Jaquan Kalani Levons,Robert Kevin Perrone,Christopher P. Price,Krishnaswamy Srinivas Raghavan,Ismat Ullah
申请号：
US12758385
公开号：
US08252821B2
申请日:
2010.04.12
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Pharmaceutical capsule compositions containing the active compound (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide, and polyethylene glycol (PEG), Vitamin E polyethylene glycol succinate, polyvinylpryrrolidone (PVP) or copovidone (PVP-Polyvinyl acetate), with or without citric acid, are provided.
